Suppr超能文献

Cullin3介导的蛋白磷酸酶2A催化亚基泛素化在肿瘤坏死因子相关凋亡诱导配体信号传导中的作用

The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling.

作者信息

Xu Jing, Zhou Jun-Ying, Xu Zhengfan, Kho Dhong-Hyo, Zhuang Zhengping, Raz Avraham, Wu Gen Sheng

机构信息

a Departments of Oncology and Pathology; Karmanos Cancer Institute ; Wayne State University School of Medicine ; Detroit , MI USA.

出版信息

Cell Cycle. 2014;13(23):3750-8. doi: 10.4161/15384101.2014.965068.

Abstract

Protein phosphatase 2A (PP2A) is the major serine-threonine phosphatase that regulates a number of cell signaling pathways. PP2A activity is controlled partially through protein degradation; however, the underlying mechanism is not fully understood. Here we show that PP2A/C, a catalytic subunit of PP2A, is degraded by the Cullin3 (Cul3) ligase-mediated ubiquitin-proteasome pathway. In response to death receptor signaling by tumor-necrosis factor-related apoptosis-inducing ligand (TRAIL), PP2A/C, caspase-8 and Cul3, a subunit of the cullin family of E3 ligases, are recruited into the death-inducing signaling complex (DISC) where the Cul3 ligase targets PP2A/C for ubiquitination and subsequent degradation. Functionally, knockdown of PP2A/C expression by siRNA or pharmacological inhibition of PP2A activity increases TRAIL-induced apoptosis. In cancer cells that have developed acquired TRAIL resistance, PP2A phosphatase activity is increased, and PP2A/C protein is resistant to TRAIL-induced degradation. Thus, this work identifies a new mechanism by which PP2A/C is regulated by Cul3 ligase-mediated degradation in response to death receptor signaling and suggests that inhibition of PP2A/C degradation may contribute to resistance of cancer cells to death receptor-induced apoptosis.

摘要

蛋白磷酸酶2A(PP2A)是调节多种细胞信号通路的主要丝氨酸 - 苏氨酸磷酸酶。PP2A的活性部分通过蛋白质降解来控制;然而,其潜在机制尚未完全了解。在这里,我们表明PP2A的催化亚基PP2A/C通过Cullin3(Cul3)连接酶介导的泛素 - 蛋白酶体途径被降解。响应肿瘤坏死因子相关凋亡诱导配体(TRAIL)的死亡受体信号传导,PP2A/C、半胱天冬酶 - 8和E3连接酶的cullin家族的一个亚基Cul3被招募到死亡诱导信号复合物(DISC)中,在那里Cul3连接酶将PP2A/C靶向泛素化并随后降解。在功能上,通过siRNA敲低PP2A/C的表达或PP2A活性的药理学抑制会增加TRAIL诱导的细胞凋亡。在已产生获得性TRAIL抗性的癌细胞中,PP2A磷酸酶活性增加,并且PP2A/C蛋白对TRAIL诱导的降解具有抗性。因此,这项工作确定了一种新的机制,通过该机制PP2A/C在响应死亡受体信号传导时由Cul3连接酶介导的降解来调节,并表明抑制PP2A/C降解可能有助于癌细胞对死亡受体诱导的细胞凋亡产生抗性。

相似文献

1
The role of Cullin3-mediated ubiquitination of the catalytic subunit of PP2A in TRAIL signaling.
Cell Cycle. 2014;13(23):3750-8. doi: 10.4161/15384101.2014.965068.
2
Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
J Biol Chem. 2013 Nov 15;288(46):33263-71. doi: 10.1074/jbc.M113.508093. Epub 2013 Oct 7.
3
Selective proteasomal degradation of the B'β subunit of protein phosphatase 2A by the E3 ubiquitin ligase adaptor Kelch-like 15.
J Biol Chem. 2012 Dec 21;287(52):43378-89. doi: 10.1074/jbc.M112.420281. Epub 2012 Nov 7.
4
A20 ubiquitin ligase-mediated polyubiquitination of RIP1 inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma.
Cancer Discov. 2012 Feb;2(2):140-55. doi: 10.1158/2159-8290.CD-11-0172. Epub 2012 Jan 24.
6
TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis.
BMC Pulm Med. 2019 Feb 7;19(1):31. doi: 10.1186/s12890-019-0786-x.
7
Inhibition of PP2A activity confers a TRAIL-sensitive phenotype during malignant transformation.
Mol Cancer Res. 2014 Feb;12(2):217-27. doi: 10.1158/1541-7786.MCR-13-0441. Epub 2013 Dec 2.
10
Rotavirus NSP1 Associates with Components of the Cullin RING Ligase Family of E3 Ubiquitin Ligases.
J Virol. 2016 Jun 10;90(13):6036-48. doi: 10.1128/JVI.00704-16. Print 2016 Jul 1.

引用本文的文献

1
Neddylation and Its Target Cullin 3 Are Essential for Adipocyte Differentiation.
Cells. 2024 Oct 5;13(19):1654. doi: 10.3390/cells13191654.
4
Endothelial Cullin3 Mutation Impairs Nitric Oxide-Mediated Vasodilation and Promotes Salt-Induced Hypertension.
Function (Oxf). 2022 Apr 8;3(3):zqac017. doi: 10.1093/function/zqac017. eCollection 2022.
6
Targeting PP2A inhibits the growth of triple-negative breast cancer cells.
Cell Cycle. 2020 Mar;19(5):592-600. doi: 10.1080/15384101.2020.1723195. Epub 2020 Feb 3.
8
Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.
Front Mol Biosci. 2018 Mar 13;5:19. doi: 10.3389/fmolb.2018.00019. eCollection 2018.
9
Developing TRAIL/TRAIL death receptor-based cancer therapies.
Cancer Metastasis Rev. 2018 Dec;37(4):733-748. doi: 10.1007/s10555-018-9728-y.

本文引用的文献

1
Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
J Biol Chem. 2013 Nov 15;288(46):33263-71. doi: 10.1074/jbc.M113.508093. Epub 2013 Oct 7.
4
Activation of the Akt survival pathway contributes to TRAIL resistance in cancer cells.
PLoS One. 2010 Apr 19;5(4):e10226. doi: 10.1371/journal.pone.0010226.
5
Serine/threonine phosphatases: mechanism through structure.
Cell. 2009 Oct 30;139(3):468-84. doi: 10.1016/j.cell.2009.10.006.
6
Alpha4 is an essential regulator of PP2A phosphatase activity.
Mol Cell. 2009 Oct 9;36(1):51-60. doi: 10.1016/j.molcel.2009.09.025.
7
Involvement of MKP-1 and Bcl-2 in acquired cisplatin resistance in ovarian cancer cells.
Cell Cycle. 2009 Oct 1;8(19):3191-8. doi: 10.4161/cc.8.19.9751. Epub 2009 Oct 7.
8
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study.
Clin Cancer Res. 2009 Sep 1;15(17):5584-90. doi: 10.1158/1078-0432.CCR-09-0996. Epub 2009 Aug 18.
10
Inhibition of serine/threonine phosphatase PP2A enhances cancer chemotherapy by blocking DNA damage induced defense mechanisms.
Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11697-702. doi: 10.1073/pnas.0905930106. Epub 2009 Jun 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验